BMC Cancer

454.7k citations
18.2k papers · · active since 1950

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Cancer Genomics and Diagnostics
    • Cancer, Hypoxia, and Metabolism
  • Oncology top 0.5%
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Cancer survivorship and care 356
    • Inflammatory Biomarkers in Disease Prognosis 284
    • Cancer Immunotherapy and Biomarkers 248
    • Cancer Cells and Metastasis 233
    • Breast Cancer Treatment Studies 265

BMC Cancer

11.8k papers receiving 315.6k citations

Peers

BMC Cancer
Comparison fields: 5 of 239
  • Cancer Research 85.2k
  • Oncology 127.8k
  • Molecular Biology 147.8k
  • Pulmonary and Respiratory Medicine 59.5k
  • Otorhinolaryngology 7.0k
Replace Frontiers in Oncology with:
Frontiers in Oncology China
Cancers United States
European Journal of Cancer United Kingdom
The Journal of Pathology United Kingdom
The Lancet Oncology United States
Cancer Letters United States
Carcinogenesis United States
Human Pathology United States
Journal of Clinical Pathology United Kingdom
Oncotarget China
BMC Cancer relative to Frontiers in Oncology China Frontiers in Oncology's profile →
Citations per field
00.5×3.8×
Frontiers in Oncology · 1×
Citations per year

Countries where authors publish in BMC Cancer

Since Specialization
Citations

This map shows the geographic impact of research published in BMC Cancer. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in BMC Cancer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BMC Cancer more than expected).

Fields of papers published in BMC Cancer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in BMC Cancer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in BMC Cancer.

About BMC Cancer

The 18.2k papers published in BMC Cancer in the last decades have received a total of 454.7k indexed citations . Papers published in BMC Cancer usually cover Oncology (2.9k papers), Cancer Research (1.1k papers), Otorhinolaryngology (297 papers), Pulmonary and Respiratory Medicine (1.6k papers) and Hepatology (342 papers) specifically the topics of Cancer survivorship and care (356 papers), Hepatocellular Carcinoma Treatment and Prognosis (313 papers), Head and Neck Cancer Studies (297 papers), Inflammatory Biomarkers in Disease Prognosis (284 papers), Breast Cancer Treatment Studies (265 papers), Cervical Cancer and HPV Research (252 papers), Cancer Immunotherapy and Biomarkers (248 papers) and Cancer Cells and Metastasis (233 papers). The most active scholars publishing in BMC Cancer are Tushar Patel, Jonathan Gleadle, Michael Michael, Hamish W. King, Martina Reberšek, Jürgen Debus, Karin Jirström, Ian A. Cree, Patrice J. Morin and Carine Michiels.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact